RecruitingPhase 2NCT02394626
Surgery for Recurrent Glioblastoma
Studying Germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Principal Investigator
- Philippe Schucht, Prof. Dr. med.Dep. of Neurosurgery, Inselspital Bern
- Intervention
- Surgery followed by adjuvant second-line therapy(procedure)
- Enrollment
- 120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2028
Study locations (25)
- Universitätsklinikum Innsbruck, Innsbruck, Austria
- Johannes Kepler University Linz University, Clinic for Neurosurgery, Linz, Austria
- Medical University of Vienna, Department of Neurosurgery, Vienna, Austria
- Centre Hospitalier Universitaire Dijon Bourgogne, Department of Neurosurgery, Dijon, France
- Hospices Civils de Lyon - CHU de Lyon, Department of Neuro-Oncology, Lyon, France
- Assistance Publique - Hôpitaux de Marseille, Department of Neuro-Oncology, Marseille, France
- Centre Hospitalier Universitaire de Nice, Department of Neurosurgery, Nice, France
- Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Neurosurgery, Paris, France
- Centre Hospitalier Universitaire de Saint-Étienne, Department of Neurosurgery, Saint-Etienne, France
- Institut de Cancérologie Strasbourg Europe (ICANS), Department of Oncology, Strasbourg, France
- Centre Hospitalier Régional et Universitaire de Tours (CHRU Tours), Department of Neurosurgery, Tours, France
- Helios Klinikum Erfurt, Erfurt, Germany
- Universitätsklinikum Münster, Münster, Germany
- Department of Neurosurgery, Hospital of Larissa & General Hospital of Larissa, Larissa, Greece
- Department of Neurosurgery, Amsterdam University Medical Center, Amsterdam, Netherlands
- +10 more locations on ClinicalTrials.gov
Collaborators
European Organisation for Research and Treatment of Cancer - EORTC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02394626 on ClinicalTrials.govOther trials for Germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07552233NK Cell Therapy for Malignant Solid Brain TumorsPeking University Third Hospital
- RECRUITINGNCT07314164Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior TreatmentIpsen
- RECRUITINGPHASE1NCT07143812A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed GlioblastomaCHA University
- RECRUITINGNANCT06910306Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaAlpha Tau Medical LTD.
- RECRUITINGNANCT07459101UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4Sunnybrook Health Sciences Centre
- RECRUITINGPHASE1, PHASE2NCT07193966NG2 and DLL3 CAR-T Cells Targeting MelanomaShenzhen Geno-Immune Medical Institute
- RECRUITINGPHASE2NCT06712927Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain MetastasesStanford University
- RECRUITINGPHASE1, PHASE2NCT06712875MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasAnn & Robert H Lurie Children's Hospital of Chicago